Latest News

Does One Need A Parachute While Jumping From An Aircraft? A Clinical Trial Addresses the Question

Parachute use on jumping from an aircraft does not reduce death or major…

ICU Stethoscopes Foster DNA from Nosocomial Bacteria

A molecular analysis of bacterial contamination on stethoscopes in an intensive care…

Flu Shot Linked to Heart Failure Survival

Patients with heart failure (HF) who receive influenza vaccination may be at…

Drug-Coated Balloon Outperforms Percutaneous Transluminal Angioplasty in Femoropopliteal Disease

A study conducted by Yongle Xu et al. demonstrated that the superiority…

Top-Ranked Hospitals Have Better Survival Rates, But Not Necessarily A Lower Risk of Readmission

Cardiology patients treated in hospitals at the top of U.S. News & World…

Does Race/Ethnicity Affect Oral Anticoagulant Use in Patients With Atrial Fibrillation?

A study by Essien and his colleagues published in JAMA aimed to…

Workplace Bullying and Violence Might be New, Potentially Modifiable Cardiovascular Risk Factors

A European study has revealed that bullying and violence are common at…

Mechanistic Study Delves Into Heart Failure Benefits Noted With Empagliflozin

The EMPA-HEART trial showed that empagliflozin resulted in beneficial effects on left…

TRED-HF: Tread With Caution While Withdrawing Heart Failure Medication in Recovered Dilated Cardiomyopathy

The results of the TRED-HF trial published in The Lancet showed that…

Does Low Dose Methotrexate Prevent Athersclerotic Events in Patients?

A randomized clinical trial that was conducted by Paul M Ridker et…

Canakinumab: A New Hope for Post MI Patients with Increased hsCRP in the Prevention of Heart Failure

Canakinumab (an IL-B inhibitor) is associated with decreased heart failure (HF) hospitalizations…

Superior Efficacy of Sacubitril-Valsartan Compared to Enalapril for lowering NT Pro-BNP in Patients Hospitalized for HFrEF

Results from a multi-center, randomized, double-blind, double dummy, parallel group clinical trial…

Dapaglifozin ‘DECLARED’ Effective in the Reduction of Heart Failure Hospitalizations in Diabetic Population

The DECLARE–TIMI 58 trial, published in the New England Journal of Medicine…